Novartis (NOT) Stock Price & News

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

About Novartis

CEOVasant Narasimhan

Employees၇.၅၃ သောင်း

Founded၁၉၉၆ မတ် ၇

Headquartersဘေဆဲလ်, Basel City, ဆွစ်ဇာလန်

Sector-

Websitenovartis.com

Revenue

Net income

All values in USD	၂၀၂၅ စက်	၂၀၂၅ ဒီ	၂၀၂၆ မတ်	၂၀၂၆ ဇွန်
Revenue	ဋေ ၁.၄၄ ထ	ဋေ ၁.၃၉ ထ	ဋေ ၁.၃၅ ထ	ဋေ ၁.၅၀ ထ
Cost of goods sold	၃၅၃.၅၀ ဋေ	၃၅၄.၂၀ ဋေ	၃၄၃.၈၀ ဋေ	၃၆၇.၈၀ ဋေ
Cost of revenue	၃၅၃.၅၀ ဋေ	၃၅၄.၂၀ ဋေ	၃၄၃.၈၀ ဋေ	၃၆၇.၈၀ ဋေ
Research and development expenses	၂၈၆.၄၀ ဋေ	၂၈၃.၇၀ ဋေ	၂၇၈.၅၀ ဋေ	၂၇၃.၉၀ ဋေ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	၃၃၀.၄၀ ဋေ	၃၄၃.၆၀ ဋေ	၃၁၃.၇၀ ဋေ	၃၂၃.၁၀ ဋေ
Operating expense	၆၂၃.၈၀ ဋေ	၆၄၆.၃၀ ဋေ	၅၉၆.၄၀ ဋေ	၆၀၉.၇၀ ဋေ
Total operating expenses	၉၇၇.၃၀ ဋေ	ဋေ ၁.၀၀ ထ	၉၄၀.၂၀ ဋေ	၉၇၇.၅၀ ဋေ
Operating income	၄၅၈.၅၀ ဋေ	၃၈၅.၅၀ ဋေ	၄၁၂.၂၀ ဋေ	၅၁၇.၆၀ ဋေ
Other non operating income	-၇.၀၀ သန်း	-၁၃.၀၀ ကုဋေ	၄.၀၀ သန်း	၁.၉၀ ကုဋေ
EBT including unusual items	၄၁၉.၆၀ ဋေ	၃၂၁.၈၀ ဋေ	၃၈၃.၉၀ ဋေ	၄၂၆.၉၀ ဋေ
EBT excluding unusual items	၄၂၉.၃၀ ဋေ	၃၄၉.၂၀ ဋေ	၃၇၈.၀၀ ဋေ	၄၇၃.၁၀ ဋေ
Income tax expense	၂၆.၆၀ ကုဋေ	၈၁.၄၀ ကုဋေ	၆၈.၃၀ ကုဋေ	၁၀၁.၂၀ ဋေ
Effective tax rate	၆.၃၄%	၂၅.၃၀%	၁၇.၇၉%	၂၃.၇၁%
Other operating expenses	၇.၀၀ ကုဋေ	၁၉.၀၀ ကုဋေ	၄.၂၀ ကုဋေ	၁၂.၇၀ ကုဋေ
Net income	၃၉၂.၈၀ ဋေ	၂၄၀.၉၀ ဋေ	၃၁၅.၆၀ ဋေ	၃၂၆.၄၀ ဋေ
Net profit margin	၂၇.၃၆%	၁၇.၃၈%	၂၃.၃၄%	၂၁.၈၃%
Earnings per share	၂.၂၅	၂.၀၃	၁.၉၉	၂.၄၁
Interest and investment income	-	၃၇.၃၀ ကုဋေ	-	-
Interest expense	-၂၈.၁၀ ကုဋေ	-၃၀.၄၀ ကုဋေ	-၃၄.၃၀ ကုဋေ	-၄၆.၂၀ ကုဋေ
Net interest expenses	-၂၈.၁၀ ကုဋေ	၆.၉၀ ကုဋေ	-၃၄.၃၀ ကုဋေ	-၄၆.၂၀ ကုဋေ
Depreciation and amortization charges	-	-	-	-
EBITDA	၅၇၇.၅၀ ဋေ	၄၉၅.၆၀ ဋေ	၅၂၃.၈၀ ဋေ	၆၂၉.၉၀ ဋေ
Gain or loss from assets sale	၈.၁၀ ကုဋေ	၈.၀၀ ကုဋေ	-၁၅.၉၀ ကုဋေ	-၂၄.၇၀ ကုဋေ

Ask anything